Psoriasis, a chronic inflammatory condition, is one of the most common skin disorders in
the United States. It affects more than 100 million people worldwide. The skin cells of
people with psoriasis multiply faster than normal, which produces raised red bumps on the
skin, often on the knees, scalp, and elbows. Though psoriasis affects such a large proportion
of adults, its causes are unclear, and it cannot currently be cured. Over the years, a link has
been found between psoriasis and an increased risk of cardiovascular disease. This
relationship is particularly pronounced in individuals who have severe psoriasis.
Ustekinumab, sold as Stelara, is an antibody that interferes with the body's inflammatory
response. It is prescribed for people whose psoriasis has not responded well to other
treatments, or who cannot tolerate other available medicines. The drug has also been
approved by the Food and Drug Administration (FDA) to treat Crohn's disease.
Courtesy: medicalnewstoday.com/
